[EGFR activating mutation in lung adenocarcinoma: risk factor of thromboembolic event?].

Abstract : Cancer is a known risk factor for the development of venous thromboembolism (VTE) and in particular, adenocarcinoma of the lung is known to be associated with a higher risk of thromboembolic event. EGFR activating mutations are more frequently found in this histological subtype than in other lung cancers. We report three cases of VTE in patients with adenocarcinoma of the lung and EGFR activating mutation. Our reported case series is atypical because the VTE event occurred early in the adenocarcinoma history: either leading to the diagnosis of cancer, or appearing very early in the management of the neoplasm.
Type de document :
Article dans une revue
Revue des Maladies Respiratoires, Elsevier Masson, 2012, 29 (9), pp.1137-40. 〈10.1016/j.rmr.2012.09.012〉
Liste complète des métadonnées

http://hal.univ-brest.fr/hal-00932193
Contributeur : Ghislaine Calvez <>
Soumis le : jeudi 16 janvier 2014 - 14:44:13
Dernière modification le : mercredi 10 janvier 2018 - 14:42:02

Identifiants

Collections

Citation

Elise Noël-Savina, Nicolas Paleiron, Grégoire Le Gal, Renaud Descourt. [EGFR activating mutation in lung adenocarcinoma: risk factor of thromboembolic event?].. Revue des Maladies Respiratoires, Elsevier Masson, 2012, 29 (9), pp.1137-40. 〈10.1016/j.rmr.2012.09.012〉. 〈hal-00932193〉

Partager

Métriques

Consultations de la notice

92